Company Filing History:
Years Active: 2006-2020
Title: Mark R Potter: Innovator in Recombinant Adeno-Associated Virus Research
Introduction
Mark R Potter is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the purification and production of recombinant adeno-associated viruses (rAAV). With a total of 2 patents, his work has implications for gene therapy and viral vector development.
Latest Patents
Mark R Potter's latest patents include innovative methods and compositions for purifying recombinant adeno-associated virus. One of his patents focuses on the purification of rAAV particles, providing essential techniques for enhancing the quality of viral vectors used in research and therapeutic applications. Another patent details the production of pseudotyped recombinant AAV virions, utilizing vectors that encode AAV Rep and Cap proteins of various serotypes. This method has resulted in the generation of pseudotyped rAAV virion stocks that are 99% pure, with titers reaching 1×10–1×10 vector genomes/ml.
Career Highlights
Mark R Potter is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance research in viral vector technology. His work is pivotal in the ongoing development of gene therapies that rely on the effective delivery of genetic material.
Collaborations
Mark has collaborated with esteemed colleagues such as Barry John Byrne and Richard O Snyder, contributing to a rich environment of innovation and research excellence.
Conclusion
Mark R Potter's contributions to the field of biotechnology, particularly in the area of recombinant adeno-associated viruses, highlight his role as a key inventor in advancing gene therapy technologies. His patents and collaborative efforts continue to influence the landscape of viral vector research.